Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OTOJV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
IKS-03
|
|||||
| Synonyms |
IKS03; IKS 03
Click to Show/Hide
|
|||||
| Organization |
Iksuda Therapeutics Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 4 Indication(s)
B-cell lymphoma [ICD11:2A86]
Phase 1
Diffuse large B-cell lymphoma [ICD11:2A81]
Phase 1
Follicular lymphoma [ICD11:2A80]
Phase 1
Mantle cell lymphoma [ICD11:2A85]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-lymphocyte antigen CD19 (CD19)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.